Compare, Analyse Sterling Biotech with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs ADCOCK INGRAM (S. Africa) - Comparison Results

STERLING BIOTECH     Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 STERLING BIOTECH   ADCOCK INGRAM
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
ADCOCK INGRAM
Jun-14
STERLING BIOTECH/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs11383-   
Low Rs3276-   
Sales per share (Unadj.) Rs26.8113.9-  
Earnings per share (Unadj.) Rs-15.0-28.7-  
Cash flow per share (Unadj.) Rs-5.5-23.8-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs54.989.4-  
Shares outstanding (eoy) m267.87168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.32.9 9.0%   
Avg P/E ratio x-0.5-11.5 4.0%  
P/CF ratio (eoy) x-1.3-13.9 9.2%  
Price / Book Value ratio x0.13.7 3.4%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,86255,608 3.3%   
No. of employees `0001.44.3 31.5%   
Total wages/salary Rs m5473,490 15.7%   
Avg. sales/employee Rs Th5,303.34,476.9 118.5%   
Avg. wages/employee Rs Th403.8813.0 49.7%   
Avg. net profit/employee Rs Th-2,959.0-1,128.1 262.3%   
INCOME DATA
Net Sales Rs m7,18119,219 37.4%  
Other income Rs m43135 31.7%   
Total revenues Rs m7,22319,354 37.3%   
Gross profit Rs m947-3,331 -28.4%  
Depreciation Rs m2,543829 306.6%   
Interest Rs m4,377521 840.8%   
Profit before tax Rs m-5,931-4,546 130.5%   
Minority Interest Rs m0-13 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,924284 -677.4%   
Profit after tax Rs m-4,007-4,843 82.7%  
Gross profit margin %13.2-17.3 -76.1%  
Effective tax rate %32.4-6.2 -519.3%   
Net profit margin %-55.8-25.2 221.4%  
BALANCE SHEET DATA
Current assets Rs m14,33514,076 101.8%   
Current liabilities Rs m49,8097,920 628.9%   
Net working cap to sales %-494.032.0 -1,542.2%  
Current ratio x0.31.8 16.2%  
Inventory Days Days403111 363.7%  
Debtors Days Days171124 137.7%  
Net fixed assets Rs m55,4328,205 675.6%   
Share capital Rs m26889 300.2%   
"Free" reserves Rs m13,9350-   
Net worth Rs m14,70115,085 97.5%   
Long term debt Rs m9,4785,301 178.8%   
Total assets Rs m73,98828,497 259.6%  
Interest coverage x-0.4-7.7 4.6%   
Debt to equity ratio x0.60.4 183.5%  
Sales to assets ratio x0.10.7 14.4%   
Return on assets %0.5-15.2 -3.3%  
Return on equity %-27.3-32.1 84.9%  
Return on capital %-6.4-19.8 32.4%  
Exports to sales %25.90-   
Imports to sales %0.20-   
Net fx Rs m1,8350-   
CASH FLOW
From Operations Rs m1,7191,640 104.8%  
From Investments Rs m-3,148-504 625.0%  
From Financial Activity Rs m1,4264,811 29.6%  
Net Cashflow Rs m-35,948 -0.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.28 Rs / ZAR

Compare STERLING BIOTECH With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare STERLING BIOTECH With: ABBOTT INDIA  FDC  CADILA HEALTHCARE  IPCA LABS  ORCHID PHARMA  



Today's Market

Sensex Ends Flat; Wipro & Hindalco Industries Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views On News

Most Popular

India: Recovery Stalled by Vaccine Games? (The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave (Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

A Stock with 700% Return Potential Comes with Additional Payoffs (Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

Why Did the Market Crash on Monday? (Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

A Unique Sector for Short-Term Profits (Fast Profits Daily)

Apr 12, 2021

This ignored sector could deliver big short-term profits.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

STERLING BIOTECH SHARE PRICE


Nov 5, 2018 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH - SHASUN PHARMA COMPARISON

COMPARE STERLING BIOTECH WITH

FEATURED VIDEOS

Market Crash: Picture Abhi Baaki Hai?

It's a Great Time to Buy Gold

The Dilemma of Investing in Bharti Airtel

Nifty: Bear Trap?

More Featured Videos

MARKET STATS